Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination.
Burkholderia cepacia complex (BCC) bacteria can cause devastating chronic infections in people with cystic fibrosis. Of particular concern is "cepacia syndrome," a rapidly progressive and usually fatal decline in health, characterized by a necrotizing bacteremic pneumonia. An important component of defense against bloodstream infections is the bactericidal action of serum. Traditional methods to determine the capacity of bacterial isolates to resist the bactericidal effects of serum are relatively low-throughput viability assays. In this study, we developed a novel growth-based assay for serum susceptibility, which allows for high throughput analysis. We applied this assay to a range of clinical isolates of BCC as well as isolates comprising the BCC experimental strain panel. Our data demonstrate that isolates from all species of BCC examined can possess serum resistant or serum sensitive/intermediate phenotypes. Of particular clinical significance, we also found no direct link between the last saved pulmonary isolate from patients who subsequently developed "cepacia syndrome" and their capacity to resist the inhibitory effects of human serum, suggesting serum resistance cannot be used as a marker of an isolate's capacity to escape from the lung and cause bacteremia.
Department of Pediatrics, Faculty of Medicine, Centre for Understanding and Preventing Infection in Children, University of British Columbia Vancouver, BC, Canada. jzlosnik@cfri.ubc.ca
James E A
JE
Zlosnik
L Cynthia
LC
Gunaratnam
David P
DP
Speert
D016470:Bacteremia / Q000382:microbiology; D001431:Bacteriological Techniques / Q000379:methods*; D001770:Blood Bactericidal Activity; D019121:Burkholderia Infections / Q000150:complications / Q000382:microbiology; D042602:Burkholderia cepacia complex / Q000276:immunology*; D003550:Cystic Fibrosis / Q000150:complications; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D050296:Microbial Viability